HARC Center: HIV Accessory and Regulatory Complexes
HARC Center: HIV Accessory and Regulatory Complexes
批准号:
9135467
负责人:
Charles Scott Craik
金额:
$27.37万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Adaptor Signaling ProteinAffectApoptosisBindingBoxingCell CycleCell Cycle ArrestCellsCleaved cellComplexData SetDegradation PathwayDendritic CellsDynein ATPaseEnzymesEukaryotic Initiation FactorsGenomicsHIVHIV GenomeHIV InfectionsHIV-1Host DefenseHuman poliovirusImmune responseIn VitroIntegration Host FactorsKnowledgeLife Cycle StagesLigaseLinkModelingMolecularMyeloid CellsN-terminalNuclear Pore ComplexPathway interactionsPeptide HydrolasesPeptide Initiation FactorsPolyproteinsPositioning AttributeProcessProkaryotic Initiation Factor-3Protein BiosynthesisProteinase 3ProteinsProteomicsRNA Recognition MotifRNA SplicingRecruitment ActivityResearchReverse TranscriptionRhinovirusRoleSiteStructureTestingTranslation InitiationTranslationsUbiquitinUbiquitinationViralVirionVirusVirus DiseasesVirus Replicationcell growthnovelprotein complextherapeutic targettripolyphosphate
中文摘要
VPR: VPR是一种保守的多功能蛋白,可被整合到病毒粒子中,并驱动病毒的早期转运
英文摘要
VPR: Vpr is a conserved multi-functional protein that is incorporated into virions and drives early (transport of
pre-integration complex) and late (apoptosis) viral life cycle steps. Despite more than 20 years of research, the
mechanism by which Vpr accelerates virus replication is not well understood [40-42]. A wide range of
molecular functions has been ascribed to Vpr, including roles in G2 cell cycle arrest and pre-integration
complexes [43-46], perhaps reflecting a multi-purpose adaptor protein. Recently, SAMHDI, a deoxynucleoside
triphosphate triphosphohydrolase, was found to be a myeloid and dendritic cell restriction factor that is
overcome by HlV-2 Vpx [47, 48], a parajog of Vpr believed to carry out some functions of Vpr. Like Vif and
Vpu, both Vpr and Vpx interact with the host ubiquitin machinery. Vpr binds the Cullin4 RING Box Ubiqultin
Ligase (CRL4) complex [49, 50], suggesting that Vpr may overcome additional host restrictions via the
degradation pathway. Due to its central roles in a number of key HIV infection processes, Vpr represents an
exciting target for structure-function studies and positions Vpr as a viable therapeutic target. With no
universally accepted model for its functions, however, only by clearly defining the host proteins and pathway(s)
perturbed by Vpr at the molecular level-as outlined in this proposal-will the bona fide targetable activity of Vpr
be revealed. The HARC Proteomics/Genomics Core compiled the most extensive Vpr-host interaction data set
described to date. Encouragingly, these novel interactions reveal host complexes and partners (e.g. dynein
and C0P9) functionally linked with many Vpr activities. By evaluating the functional significance and ability to
form structured complexes, we will develop and test new hypotheses about Vpr-host interactions.
PR: Many viruses encode proteases that disarm host defenses or hijack host processes in addition to cleaving
viral substrates. For example, poliovirus PR inhibits host protein synthesis by cleaving translation initiation
factors, while rhinovirus PR cleaves the nuclear pore complex and adaptor proteins involved in the innate
immune response [51-58]. HIV-1 PR processes the viral Gag and GagPol polyproteins during virion
maturation, but its role in affecting host functions is unclear. In vitro, PR cleaves several mammalian proteins
[59-65], but it is not known if cleavage occurs during HIV infection or how much active enzyme exists in host
cells during the viral life cycle [66, 67]. The HARC Center Proteomics/Genomics Core uncovered novel host
proteins that interact with, an inactive version of PR, including proteins involved in immune responses, splicing,
translation, cell growth, and apoptosis [1, 29]. Active PR in cells cleaved some of these proteins, including a
single site in the RNA binding domain of the d subunit of the eukaryotic translation initiation factor 3 complex
(elF3d). elF3d was cleaved nearly as efficiently as Gag. An intriguing hypothesis is that elF3d recruits the
translation initiation complex to the entering HIV genome, obstructing reverse transcription. Our structural
studies of such PR-host complexes will be the first of PR with a macromolecular substrate, providing new
knowledge on substrate recognition. Our analyses of the roles of potential host PR substrates in HIV
replication have the potential to establish new paradigms for PR function, link PR to the roles of Vit Vpu, and
Vpr, and define the structures of novel PR-host complexes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing Antivirals Targeting Proteases and Polymerases of Coronaviruses, Picornaviruses and Bunyavirales
-
批准号:10512628
-
项目类别:
-
资助金额:$516.83万
-
财政年份:2022
-
负责人:Charles Scott Craik
-
依托单位:
New radiotracer development to study immune cell mobilization of granzyme proteolytic activity
-
批准号:10231735
-
项目类别:
-
资助金额:$67.68万
-
财政年份:2021
-
负责人:Charles Scott Craik
-
依托单位:
New radiotracer development to study immune cell mobilization of granzyme proteolytic activity
-
批准号:10395587
-
项目类别:
-
资助金额:$74.04万
-
财政年份:2021
-
负责人:Charles Scott Craik
-
依托单位:
New radiotracer development to study immune cell mobilization of granzyme proteolytic activity
-
批准号:10591415
-
项目类别:
-
资助金额:$66.04万
-
财政年份:2021
-
负责人:Charles Scott Craik
-
依托单位:
Probing the Role of Chaperone-TPR Complexes in Tau Proteostasis
-
批准号:10029781
-
项目类别:
-
资助金额:$224.04万
-
财政年份:2020
-
负责人:Charles Scott Craik
-
依托单位:
Non-invasive Differentiation of Benign Lesions from Aggressive Pancreatic Cancer
-
批准号:8823694
-
项目类别:
-
资助金额:$17.21万
-
财政年份:2015
-
负责人:Charles Scott Craik
-
依托单位:
Extracellular Proteolysis as a Molecular Stratification Tool for Cancer
-
批准号:8829207
-
项目类别:
-
资助金额:$16.83万
-
财政年份:2014
-
负责人:Charles Scott Craik
-
依托单位:
Antibodies for Characterizing the Structure and Function of Proteases
-
批准号:8702411
-
项目类别:
-
资助金额:$34.26万
-
财政年份:2014
-
负责人:Charles Scott Craik
-
依托单位:
Allosteric Inhibition of a Family of Proteolytic Enzymes
-
批准号:8577916
-
项目类别:
-
资助金额:$30.38万
-
财政年份:2013
-
负责人:Charles Scott Craik
-
依托单位:
Allosteric Inhibition of a Family of Proteolytic Enzymes
-
批准号:8698774
-
项目类别:
-
资助金额:$30.52万
-
财政年份:2013
-
负责人:Charles Scott Craik
-
依托单位:
Allosteric Inhibition of a Family of Proteolytic Enzymes
-
批准号:9039629
-
项目类别:
-
资助金额:$30.67万
-
财政年份:2013
-
负责人:Charles Scott Craik
-
依托单位:
CHARACTERIZATION COVALENT INHIBITORS OF SERINE, CYSTEINE & ASPARTYL PROTEINASE
-
批准号:8363756
-
项目类别:
-
资助金额:$5.98万
-
财政年份:2011
-
负责人:Charles Scott Craik
-
依托单位:
CHARACTERIZATION COVALENT INHIBITORS OF SERINE, CYSTEINE & ASPARTYL PROTEINASE
-
批准号:8169750
-
项目类别:
-
资助金额:$6.83万
-
财政年份:2010
-
负责人:Charles Scott Craik
-
依托单位:
A Technological Platform for the Identification of Serine Proteases in Cancer
-
批准号:7895790
-
项目类别:
-
资助金额:$35.47万
-
财政年份:2009
-
负责人:Charles Scott Craik
-
依托单位:
A Technological Platform for the Identification of Serine Proteases in Cancer
-
批准号:8192929
-
项目类别:
-
资助金额:$34.15万
-
财政年份:2009
-
负责人:Charles Scott Craik
-
依托单位:
TARGETTING CYSTEINE PROTEINASES OF THE SARS-ASSOCIATED CORONAVIRUS
-
批准号:7955484
-
项目类别:
-
资助金额:$0.89万
-
财政年份:2009
-
负责人:Charles Scott Craik
-
依托单位:
CHARACTERIZATION COVALENT INHIBITORS OF SERINE, CYSTEINE & ASPARTYL PROTEINASE
-
批准号:7957390
-
项目类别:
-
资助金额:$1.09万
-
财政年份:2009
-
负责人:Charles Scott Craik
-
依托单位:
A Technological Platform for the Identification of Serine Proteases in Cancer
-
批准号:7582321
-
项目类别:
-
资助金额:$44.61万
-
财政年份:2009
-
负责人:Charles Scott Craik
-
依托单位:
TARGETTING CYSTEINE PROTEINASES OF THE SARS-ASSOCIATED CORONAVIRUS
-
批准号:7723494
-
项目类别:
-
资助金额:$0.58万
-
财政年份:2008
-
负责人:Charles Scott Craik
-
依托单位:
CHARACTER COVALENT INHIBITORS OF SERINE, CYSTEINE & ASPARTYL PROTEINASE: HIV
-
批准号:7724194
-
项目类别:
-
资助金额:$1.51万
-
财政年份:2008
-
负责人:Charles Scott Craik
-
依托单位:
海外基金